News

Orezone Gold Unveils Final Prospectus for Major Funding

Orezone Gold Unveils Final Prospectus for Major Funding

Orezone Gold Corporation Files Final Prospectus

Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) is excited to share significant news regarding its latest financing strategy. A final short form prospectus has been filed, marking a vital step in the company’s journey towards expanding its gold production capabilities. This prospectus, dated recently, outlines plans for a bought deal offering of common shares, raising an impressive C$35 million in total gross proceeds.

Details of the Offering

The prospectus qualifies the distribution of up to 42,683,000 common shares at an offering price of C$0.82 each. This funding not only allows Orezone to bolster its financial backbone but also opens the door for future developments and expansions of their flagship Bomboré Gold Mine.

Furthermore, there’s an option to issue an additional 6,402,450 common shares, depending on market demand. The closing of this offering is anticipated soon, pending routine regulatory approvals and conditions typical for such transactions.

Accessing the Final Prospectus

For potential investors and other interested parties, the final short form prospectus is accessible through the company’s profile on SEDAR+. This document will provide critical insights into Orezone's offering and plans, helping investors make informed decisions aligned with their financial goals.

Enhancing Production at Bomboré Gold Mine

The Bomboré Gold Mine, situated in Burkina Faso, is at the heart of Orezone's ambitious expansion. Following its achievement of commercial production in late 2022, the mine is transitioning into a new phase that emphasizes hard rock operations. By enhancing its production capabilities, Orezone expects to increase both annual output and overall life-of-mine gold production significantly.

Company Commitment to Sustainability

Orezone's commitment to responsible mining is more than just a corporate ethos; it's a core principle guiding its operations. The leadership team, known for their expertise in project construction and operations, is focused on fostering sustainable practices that benefit both the environment and local communities.

Expertise and Experience in Mining

Under the guidance of Patrick Downey, President and CEO, Orezone is making strides in the mining sector. With a dedicated team focused on maximizing the potential of the Bomboré project and ensuring social responsibility, Orezone stands at a promising juncture for growth.

Additionally, the technical report regarding the Bomboré Phase II Expansion is available, further detailing the strategies that will be implemented to enhance the mine's output and strength.

Contacting Orezone Gold Corporation

For any inquiries or more detailed information, Orezone invites potential investors and interested parties to reach out via their contact numbers or email. Patrick Downey and Kevin MacKenzie are readily available for dialogue regarding investment and corporate development.

Frequently Asked Questions

What is the purpose of the final short form prospectus?

The final short form prospectus aims to secure C$35 million through a bought deal, enabling Orezone to enhance its mining operations and support future projects.

How many common shares are being offered?

Orezone is offering 42,683,000 common shares at a price of C$0.82 each, with the possibility of an additional 6,402,450 shares depending on demand.

What does Orezone specialize in?

Orezone Gold Corporation specializes in gold mining, focusing primarily on its flagship Bomboré Gold Mine located in Burkina Faso, West Africa.

Who are the key executives at Orezone?

Patrick Downey serves as the President and CEO, while Kevin MacKenzie is the Vice President of Corporate Development and Investor Relations.

How can I access the final prospectus?

The final prospectus is accessible on SEDAR+, allowing potential investors to review all details related to the offering and Orezone's operations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 80

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Mendocino Farms Faces Allegations Over Employee Practices

Updated Category News Views 8

Mendocino Farms Lands in Legal Hot Water Jobs pay the bills and keep the gears turning. But when a company like Mendocino Farms allegedly chucks out the rulebook, things get messy fast. We're talking about a hefty lawsuit aimed at this chain, accusing them of playing fast and loose with California's labor laws. If you've been around the block like me, you know that...

Continue Reading
Patriot Fund Gala Celebrates Veterans and America's 250th

Updated Category News Views 21

Celebrating Service and Patriotism in Philadelphia The Patriot Fund is gearing up for its 11th Annual Gala, a night dedicated to honoring the veterans who have sacrificed so much for this nation. Set against the historic backdrop of Philadelphia, the gala coincides with America's 250th anniversary—couldn't have picked a better time or place for such an event. It’s not...

Continue Reading
Zoomlion's Tower Cranes: Engineering Feats at Great Heights

Updated Category News Views 5

Pushing Boundaries with Towering Achievements When you're looking up at an engineering marvel, there's a good chance mighty cranes had their heyday lifting those towering ambitions. Zoomlion Heavy Industry Science & Technology Co., Ltd. just pulled a power move at the Lugu Lake Grand Bridge's 283-meter Shangri-La-side main tower. Picture that: two R4300-200 bad boys...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 4

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Callender Bowlin's Legal Eagles Soar in Texas 2026

Updated Category News Views 4

The Spotlight on CB Trial's Legal Titans Roll the dice, folks—who stands up in Texas’ legal playground? It's Callender Bowlin, PLLC's hotshots again securing their hallmark in the 2026 Texas Super Lawyers gauntlet. This ain’t their first rodeo, either. Founding partners Mark Callender and Josh Bowlin—names synonymous with high-stakes litigation—continue to bask...

Continue Reading
Vinitaly.USA 2026: Italian Wine Takes Manhattan

Updated Category News Views 11

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 44

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Bidease Taps Moloco Veteran Dock Kim for Growth Role

Updated Category News Views 7

In the rough-and-tumble world of mobile advertising, cutting through the noise with real results is no easy feat. Yet Bidease finds itself riding high on a wave of growth—200% revenue increase over back-to-back years. That's no small potatoes, and now they're topping it off with a savvy hire: Dock Kim, the former revenue honcho at Moloco, is on deck as the new VP of...

Continue Reading
HumanView Relaunch: LEAP Group Decodes Customer Signals

Updated Category News Views 14

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Continue Reading

Top 5 Most Recently Viewed Articles

Domyn Unveils New Era in Responsible AI for Critical Sectors

Updated Category News Views 480

Introducing Domyn: Redefining AI Solutions for Regulated Industries Domyn has emerged as the new name for iGenius, a pioneer in the realm of Responsible AI, specifically tailored for industries subject to rigorous regulations, such as government, finance, and heavy industry. With a commitment to providing cutting-edge AI solutions, Domyn aims to bridge the gap between...

Continue Reading
Pelican Intl Inc. Strengthens Position in Paddlesport Market

Updated Category News Views 326

Pelican Intl Inc. Expands Assets for Future Growth Renewed stability and a bold vision for long-term growth for the paddlesport market leader with U.S. and Canadian manufacturing operations. Pelican Intl Inc., a newly formed entity, proudly announces the successful acquisition of assets from Pelican International Inc. and Confluence Outdoor Inc. through a court-approved...

Continue Reading
Rocket Lab's Ascendancy in the Global Space Launch Sector

Updated Category News Views 154

Rocket Lab's Rise in the Aerospace and Defense Sector The positive news keeps flowing for Rocket Lab USA, Inc. (NASDAQ: RKLB), a noteworthy player in the aerospace and defense industry. The momentum began with a significant upgrade from analysts at Cantor Fitzgerald, who raised their price target for the company. Recently, Rocket Lab has also been selected by the European...

Continue Reading
Concerns Rise for Customers Bancorp Following Federal Review

Updated Category News Views 126

Customers Bancorp in Hot Water Over Risk Management Failures Customers Bancorp, Inc. (CUBI) has found itself under the magnifying glass as the Federal Reserve drops some sobering news about its risk management and compliance practices. Investors are feeling jittery—especially those nursing heavy losses—as they grapple with unsettling revelations about potential flaws...

Continue Reading
Bristol Myers Secures EC Approval for Innovative Liver Cancer Therapy

Updated Category News Views 232

Bristol Myers' Dual Immunotherapy Gains Approval The European Commission (EC) has granted approval to Bristol Myers Squibb & Co's Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for treating adult patients facing unresectable or advanced hepatocellular carcinoma (HCC), a prevalent form of liver cancer. This is a pivotal advancement in onco-immunotherapy....

Continue Reading